Business Context and Reporting Period
This Form 8-K Current Report was filed by Innospec Inc. on June 2, 2026. The report details a corporate governance change involving the Board of Directors, effective as of the report date.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on director compensation and appointment details.
- Director Annual Cash Retainer: $100,000
- Audit Committee Additional Retainer: $5,000
- Expected Annual Equity Grant Value: $125,000
- Additional Daily Fee (if requested): $2,000
Material Changes
The Board of Directors increased the number of directors from seven (7) to eight (8). Shelley Bausch was appointed as a Class II director, effective July 1, 2026, serving until the 2027 annual meeting of stockholders or until a successor is elected. She was also appointed to the Audit Committee effective July 1, 2026.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on business outlook, or discussion of risks and contingencies. It confirms there are no undisclosed arrangements or conflicts of interest regarding Ms. Bausch's appointment under Item 404(a) of Regulation S-K.
Investor Verification Checklist
- Verify the effective date of Shelley Bausch's directorship (July 1, 2026) and her term expiration (2027 annual meeting).
- Confirm the structure of the equity grant (Restricted Stock Units vesting over three years) and the valuation basis (closing price prior to grant date).
- Review the total compensation package for non-employee directors to assess alignment with peer companies.
- Check subsequent filings for the actual grant date and value of the equity award in February 2027.